115 related articles for article (PubMed ID: 37098223)
1. Changes in cervical dysplasia, carcinoma in situ, and cervical cancer after expanding the National Cancer Screening Program to younger women in Korea.
Kim W; Chun S; Lee SA
Int J Qual Health Care; 2023 May; 35(2):. PubMed ID: 37098223
[TBL] [Abstract][Full Text] [Related]
2. Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.
Oh CM; Jung KW; Won YJ; Shin A; Kong HJ; Jun JK; Park SY
PLoS One; 2013; 8(8):e72012. PubMed ID: 23977194
[TBL] [Abstract][Full Text] [Related]
3. Assessment of cervical cancer screening policy in Korea for women over age 65.
Lee S; Park HT; Hong JH; Song JY; Lee JK; Lee NW; Kim T; Lee KW
J Geriatr Oncol; 2013 Oct; 4(4):382-7. PubMed ID: 24472483
[TBL] [Abstract][Full Text] [Related]
4. Performance of papanicolaou testing and detection of cervical carcinoma in situ in participants of organized cervical cancer screening in South Korea.
Han MA; Choi KS; Lee HY; Jun JK; Jung KW; Kang S; Park EC
PLoS One; 2012; 7(4):e35469. PubMed ID: 22530028
[TBL] [Abstract][Full Text] [Related]
5. Cervical cytology in Greenland and occurrence of cervical carcinoma, carcinoma in situ, and dysplasia. Extent and impact of uncoordinated screening activity 1976-1985.
Højgaard Nielsen N; Jensen H; Hansen PK
Arctic Med Res; 1988 Oct; 47(4):179-88. PubMed ID: 3214508
[No Abstract] [Full Text] [Related]
6. Positive diagnostic values and histological detection ratios from the Rotterdam cervical cancer screening programme.
Kreuger FA; Beerman H; Nijs HG; van Ballegooijen M
Int J Epidemiol; 1998 Jun; 27(3):377-81. PubMed ID: 9698123
[TBL] [Abstract][Full Text] [Related]
7. Trend analysis of process quality indicators for the Korean National Cervical Cancer Screening Program from 2005 to 2013.
Bui CN; Choi E; Suh M; Jun JK; Jung KW; Lim MC; Choi KS
J Gynecol Oncol; 2021 Jan; 32(1):e14. PubMed ID: 33327046
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening in an urban emergency department.
Hogness CG; Engelstad LP; Linck LM; Schorr KA
Ann Emerg Med; 1992 Aug; 21(8):933-9. PubMed ID: 1497160
[TBL] [Abstract][Full Text] [Related]
9. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cervical cancer screening among women with and without hysterectomies: a nationwide population-based study in Korea.
Shin JY; Choi KS; Suh M; Park B; Jun JK
BMC Cancer; 2018 Aug; 18(1):810. PubMed ID: 30098592
[TBL] [Abstract][Full Text] [Related]
11. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
[TBL] [Abstract][Full Text] [Related]
12. Population screening for cervical cancer in The Netherlands. A report by the Evaluation Committee.
Int J Epidemiol; 1989 Dec; 18(4):775-81. PubMed ID: 2695473
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of cervical intraepithelial neoplasia in sexually active teenagers and young adults. Results of data analysis of mass Papanicolaou screening of 796,337 women in the United States in 1981.
Sadeghi SB; Hsieh EW; Gunn SW
Am J Obstet Gynecol; 1984 Mar; 148(6):726-9. PubMed ID: 6702940
[TBL] [Abstract][Full Text] [Related]
14. Effect of regular 3-yearly screening on the incidence of cervical smears: the Leiden experience.
Boon ME; de Graaff Guilloud JC; Rietveld WJ; Wijsman-Grootendorst A
Cytopathology; 1990; 1(4):201-10. PubMed ID: 2101670
[TBL] [Abstract][Full Text] [Related]
15. Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population.
Friedell GH; Tucker TC; McManmon E; Moser M; Hernandez C; Nadel M
J Natl Cancer Inst; 1992 Jul; 84(13):1030-2. PubMed ID: 1608055
[TBL] [Abstract][Full Text] [Related]
16. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995.
Horwitz LA
J Nurse Midwifery; 1999; 44(2):165-6. PubMed ID: 10328696
[No Abstract] [Full Text] [Related]
17. [Three-year follow-up results of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an alternative screening method for cervical cancer in rural areas].
Zhang YZ; Ma JF; Zhao FH; Xiang XE; Ma ZH; Shi YT; Hu SY; Qiao YL
Chin J Cancer; 2010 Jan; 29(1):4-8. PubMed ID: 20038302
[TBL] [Abstract][Full Text] [Related]
18. The mode ages of women with cervical dysplasia.
Carson HJ; DeMay RM
Obstet Gynecol; 1993 Sep; 82(3):430-4. PubMed ID: 8355947
[TBL] [Abstract][Full Text] [Related]
19. Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer.
Kim SC; Gillet VG; Feldman S; Lii H; Toh S; Brown JS; Katz JN; Solomon DH; Schneeweiss S
Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1239-44. PubMed ID: 24027140
[TBL] [Abstract][Full Text] [Related]
20. Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical Cancer.
Edvardsson H; Wang J; Andrae B; Sparén P; Strander B; Dillner J
Acta Cytol; 2021; 65(5):377-384. PubMed ID: 34077926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
